• Building Biotechs
  • Posts
  • The secret to transforming scientific concepts into marketable products

The secret to transforming scientific concepts into marketable products

Plus: Strong IPOs, Houston Innovation Hub, and more

Author

Carina Clingman
October 30, 2024

In partnership with

What’s the secret to transforming scientific concepts into marketable products?

This week, we're exploring operations and commercialization in biotech startups.

I enjoyed speaking with Stacie Frye, co-founder and CCO of Stimulus Bio. Stacie brings invaluable insights from her unique journey across marketing, chemical engineering, and helping to build and successfully exit two biotech startups.

We discussed biotech startups' challenges when transitioning from the lab to the market. Stacie emphasized the importance of effective storytelling in communicating complex scientific concepts to investors and customers. We discussed strategies for building a strong team that can bridge the gap between scientific innovation and commercial success.

Tune in to learn how to position your biotech innovations effectively in the market and build a successful commercial strategy.

What’s inside:

  • PODCAST EPISODE: The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio

  • CAREER CORNER: Breaking into Biotech Webinar (with yours truly as a panelist)

  • BIOTECH NEWS: Strog IPOs, Investor Sentiment, WiXi, and Houston

The Building Biotechs Podcast

The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio

In this episode, I had a fun conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs.

Career Corner

Webinar: Breaking into Biotech

This week I was a panelist on a BioSpace/Johns Hopkins presentation to help early-career scientists break into biotech. It was a lot of fun, and we shared industry insights, tips on applying and interviewing, and so much more.

Get a List of the Best HRIS Software for Your Company

  • Get a tailored vendor shortlist based on your unique needs

  • Personalized 1:1 help from HR software expert

  • Save time and money with expert research

Stories We’re Following

The Week’s 10 Biggest Funding Rounds: Seaport Therapeutics And Zip Top Big Money Week

Another big week for biotech, as startups in the sector scooped up multiple spots on this week’s list. However, there also were big rounds in industries like procurement, energy and robotics. All in all, a half-dozen companies raised rounds of $100 million or more.

What I Wish I Knew When I Started A Company: 4 Insights For Founders From A VC

Starting a company is equal parts thrilling and daunting, writes Rob Biederman of Asymmetric Capital Partners, who shares four insights he wishes he'd known when embarking on the startup path.

U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names

Three sizable IPOs priced this past week, joined by a flurry of small issuers and blank check companies - Ingram Micro, Septerna, and WeRide.

WuXi AppTec Remains Resilient Amid Threat from BIOSECURE Act, Continues to Attract New Clients

As the Chinese contract manufacturer awaits the U.S. Senate’s consideration of the BIOSECURE Act, it has added 800 new customers in the first nine months of 2024, while being hit with a 2% revenue decline in the third quarter.

Houston's top innovation leaders talk the city's strengths, weaknesses

InnnovationMap asked each Ecosystem Builder finalist to share their thoughts on the strengths and weaknesses of the local innovation ecosystem and about the roles they're playing in the scene's evolution.

Did someone forward this to you? Wow, you have great friends! Join Our Newsletter to Stay Plugged In.